New York, NY (PRWEB) March 07, 2013
On March 7, Voices Against Brain Cancer (VABC) applauds Chris Elliott Fund, which – according to an article from Seattle Pi – recently hosted a webinar focused on insurance options and financial resources for brain cancer patients.
Seattle Pi reports that the webinar, “A Brain Tumor Patient's Guide to Insurance & Financial Resources,” was hosted on February 28th by Chris Elliott fund, an advocacy organization for brain cancer patients. According to the article, the free webinar was really helpful for brain tumor patients and anyone affected by any type of tumor or cancer was encouraged to register.
This webinar is Chris Elliott Fund’s second installment. “Brains Matter Webinar Series offered unique educational information to help brain tumor patients along their journey of treatment.” Several experts on cancer research, treatment and care will be taking part in the webinars.
Michael Klipper, Chairman of VABC, applauded the group’s efforts to help brain cancer patients. “The fact that they are dedicating a whole year to provide free advice for cancer patients is truly great,” he said. “It is unfortunate how financially devastating brain cancer can be, on top of the emotional and physical toll it takes on patients and their families, but finding help from charitable organizations like this one makes a huge difference.”
VABC has a wide variety of initiatives in place for brain cancer research, awareness and support. The organization’s research grants fund cutting-edge research programs that will have a monumental impact on the diagnosis and treatment of brain cancer. VABC currently funds research at several esteemed institutions such as Brookhaven National Laboratory, Cleveland Clinic, Columbia, Cornell, Duke, Harvard, John Hopkins, Memorial Sloan-Kettering and Yale, to name a few.
VABC's mission is to find a cure for brain cancer by advancing scientific research, increasing awareness within the medical community and supporting patients, their families and caregivers afflicted with this devastating disease.
For press inquiries, please contact: 5W Public Relations.